Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjen H G Cleven

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Surgical Pathology Clinics|August 12, 2017
Hematopoietic Tumors Primarily Presenting in BoneArjen H G Cleven, Pancras C W Hogendoorn
Clinical Orthopaedics and Related Research|May 21, 2019
Can Navigation Improve the Ability to Achieve Tumor-free Margins in Pelvic and Sacral Primary Bone Sarcoma Resections? A Historically Controlled StudySarah E Bosma, Arjen H G Cleven, P D Sander Dijkstra
Virchows Archiv : an International Journal of Pathology|December 16, 2019
Molecular findings in maxillofacial bone tumours and its diagnostic valueArjen H G Cleven, Willem H Schreuder, Eline Groen, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|April 25, 2007
Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomasArjen H G Cleven, Manon van Engeland, Bradly G Wouters, et al.
Case Reports in Dentistry|November 29, 2023
Treatment of Progressive Cherubism during the Second Dental Transitional Phase with CalcitoninEthan Meijer, Henk van den Berg, Arjen H G Cleven, et al.
Journal of the American Society for Mass Spectrometry|November 23, 2016
Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry ImagingSha Lou, Benjamin Balluff, Arjen H G Cleven, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|October 12, 2016
An experimental guideline for the analysis of histologically heterogeneous tumors by MALDI-TOF mass spectrometry imagingSha Lou, Benjamin Balluff, Arjen H G Cleven, et al.
Histopathology|July 13, 2019
Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysisSuk Wai Lam, Kirsten van Langevelde, Albert J H Suurmeijer, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2016
Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapyYayan T Sundara, Marie Kostine, Arjen H G Cleven, et al.
The American Journal of Surgical Pathology|October 13, 2015
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and ChondroblastomaArjen H G Cleven, Saskia Höcker, Inge Briaire-de Bruijn, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Surgical Pathology Clinics|August 12, 2017
Hematopoietic Tumors Primarily Presenting in BoneArjen H G Cleven, Pancras C W Hogendoorn
Clinical Orthopaedics and Related Research|May 21, 2019
Can Navigation Improve the Ability to Achieve Tumor-free Margins in Pelvic and Sacral Primary Bone Sarcoma Resections? A Historically Controlled StudySarah E Bosma, Arjen H G Cleven, P D Sander Dijkstra
Virchows Archiv : an International Journal of Pathology|December 16, 2019
Molecular findings in maxillofacial bone tumours and its diagnostic valueArjen H G Cleven, Willem H Schreuder, Eline Groen, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|April 25, 2007
Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomasArjen H G Cleven, Manon van Engeland, Bradly G Wouters, et al.
Case Reports in Dentistry|November 29, 2023
Treatment of Progressive Cherubism during the Second Dental Transitional Phase with CalcitoninEthan Meijer, Henk van den Berg, Arjen H G Cleven, et al.
Journal of the American Society for Mass Spectrometry|November 23, 2016
Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry ImagingSha Lou, Benjamin Balluff, Arjen H G Cleven, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|October 12, 2016
An experimental guideline for the analysis of histologically heterogeneous tumors by MALDI-TOF mass spectrometry imagingSha Lou, Benjamin Balluff, Arjen H G Cleven, et al.
Histopathology|July 13, 2019
Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysisSuk Wai Lam, Kirsten van Langevelde, Albert J H Suurmeijer, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2016
Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapyYayan T Sundara, Marie Kostine, Arjen H G Cleven, et al.
The American Journal of Surgical Pathology|October 13, 2015
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and ChondroblastomaArjen H G Cleven, Saskia Höcker, Inge Briaire-de Bruijn, et al.
Pageof 6